Pooja Ghatalia, MD

Dr. Ghatalia

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111


Assistant Professor, Department of Hematology/Oncology

Collaborating Member, Cancer Epigenetics

Kidney, Bladder, and Prostate Cancer TRDG Member


Treatment Focus

Chemotherapy, targeted chemotherapy, immunotherapy, hormone therapy, clinical trials for genitourinary malignancies

Research Program

Treatment Philosophy

I am a medical oncologist specializing in genitourinary cancers. Treating patients with cancer is a privilege for me as in the process of diagnosing and treating the illness I get to become the patient’s friend, resource and advocate. In the most difficult times of their life, each cancer patient and their family deserves the best possible care. I strive to provide excellent care by being a good listener, maintaining good communication with patients and my team, staying abreast with the rapidly evolving field of oncology and by providing individualized care to each patient.

I came to Fox Chase for my fellowship and stayed here because I loved the team and realized that at Fox Chase, each patient has the benefit of an interdisciplinary team working together to ensure the highest quality care. This team approach is crucial in determining and implementing the best treatment plan.

In my clinical practice I focus on the care of patients with kidney, prostate bladder, penile, adrenal and testicular cancer and I am proud to be part of a large multidisciplinary team of distinguished clinicians and researchers at Fox Chase.  Over the last decade, the number of treatment options for patients with advanced cancers has greatly expanded and at Fox Chase we can offer both the latest standard-of-care as well as new experimental approaches. My particular research interest is in developing biomarkers that can help understand the behavior of kidney cancers as well as clinical trial development for genitourinary cancers.

Education and Training

Educational Background

  • Fellowship, Hematology/Oncology, Temple University/ Fox Chase Cancer Center, Philadelphia, PA
  • Residency, Internal Medicine, University of Alabama at Birmingham, AL
  • MD, Albany Medical College (Cum Laude), Albany, NY, 2012


  • ABIM Board Certified in Hematology and Medical Oncology


  • American Society of Clinical Oncology
  • American Society of Hematology
  • American College of Physicians
  • Alpha Omega Alpha Honor medical society
  • American Medical Association

Honors & Awards

  • ASCO/AACR Molecular Biology in Clinical Oncology Workshop Selected Participant, Snowmass, CO, 2017
  • Kidney Cancer Association Young Investigator Award Research Grant, 2017
  • Trainees in Internal Medicine Mentored Experience in Research (TIME-R) award, 2014
Research Profile

Research Program


Selected Publications

Ghatalia P, Nagarathinam R, Cooper H, Geynisman DM, El-Deiry WS. Mismatch repair deficient metastatic colon cancer and urothelial cancer: a case report of sequential immune checkpoint therapy. Cancer biology and Therapy 2017 July. [Epub ahead of print]

Ghosh AP, Willey CD, Anderson, JC, Welaya K, Mehta, A, Ghatalia P. Kinomic Profiling Identifies Focal Adhesion Kinase 1 as a Therapeutic Target in Advanced Clear Cell Renal Cell Carcinoma. OncoTarget 2017 Apr; 8(17): 29220-32. Cited in Pubmed; PMID: 28418903

Ghatalia P, Zibelman M, Geynisman DM, Plimack ER Checkpoint inhibitors for the Treatment of Renal Cell Carcinoma. Current Treatment Options in Oncology 2017 Jan; 18(1): 7. Cited in Pubmed; PMID: 28210995

Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE, Viterbo R, Geynisman DM, Kutikov A, Plimack ER, Smaldone MC, Wong YN, Bilusic M. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clinical Genitourinary Cancer. 2016 Sep. [Epub ahead of print]. Cited in Pubmed; PMID 27991416

Ghatalia P, Yang E, Lasseigne BN, Ramaker RC, Cooper SJ, Chen D, Sudarshan S, Wei S, Guru A, Zhao A, Cooper T, Naik G, Myers RM, Sonpavde G. Kinase gene expression profiling of metastatic clear cell renal cell carcinoma tissue identifies potential new drivers and therapeutic targets. PLOS One 2016 Aug; 11 (8). Cited in Pubmed; PMID 27574806

Zibelman M, Ghatalia P, Geynisman D, Plimack E. Checkpoint Inhibitors for Renal Cell Carcinoma: Current Landscape and Future Directions. Immunotherapy. 2016 June; 8: 785-98. Cited in Pubmed; PMID 27349978

Ghatalia P, Morgan C, Sonpavde G. Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials. Critical Reviews in Oncology/ Hematology. 2016 Feb; 98: 122-36. Cited in Pubmed; PMID 26597016

Anderson JC, Willey CD, Mehta A, Welaya K, Chen D, Duarte CW, Ghatalia P, Arafat W, Madan A, Sudarshan S, Naik G, Grizzle WE, Choueiri TK, Sonpavde G. High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes. PLoS One. 2015 Sep 25;10 (9). Cited in Pubmed; PMID 26406598

Ghatalia P, Je Y, Nguyen PL, Trinh QD, Choueiri TK, Sonpavde G. Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials. Critical Reviews in Oncology/ Hematology. 2015 Aug; 95(2):251-63. Cited in Pubmed; PMID 25900071

Ghatalia P, Je Y, Kaymakcalan MD, Sonpavde G, Choueiri TK. QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors. British Journal of Cancer. 2015 Jan; 112(2): 296-305. Cited in Pubmed; PMID 25349964

Ghatalia P, Morgan C, Choueiri TK, Sonpavde G. Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Critical Reviews in Oncology/ Hematology. 2015 May; 94(2): 228-37 PMID 25577572

Ghatalia P, Morgan C, Choueiri TK, Rocha P, Naik G, Sonpavde G. Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Critical Reviews in Oncology/ Hematology. 2015 Apr; 94(1):136-45 PMID 25541349

Ghatalia P, Je Y, Mouallem NE, Nguyen PL, Trinh Q, Sonpavde G, Choueiri TK. Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials. Critical Reviews in Oncology/Hematology. 2015 Mar; 93(3):257-76. Cited in Pubmed; PMID 25523486

Ghatalia P, Vick A, Vattoth S, Roberson G, Pappas P. Reversible blindness in cryptococcal meningitis with normal intracranial pressure. Clinical Infectious Diseases. 2014 July; 59(2): 310-3. Cited in Pubmed; PMID 24704725

Ghatalia P, Porter J, Wroblewski D, Carlson JA. Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager. Journal of Cutaneous Pathology. 2013 May; 40(5): 477-84. Cited in Pubmed; PMID 23578183



Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.


5.0 / 5.0


  • 5.0
  • 5.0
  • 5.0
  • 5.0
  • 5.0


  • 5.0
    July 31, 2020
    Overall experience at Fox Chase is very good, staff are helpful & respectful. Dr. Ghatalia is excellent! She is professional as well as a sincere, caring person. My wife and I have the utmost respect for her as a physician, confident in her skills as an oncologist and is a serious, caring individual. She exceeds all expectations.
  • 5.0
    July 27, 2020
    A good experience each time.
  • 5.0
    July 24, 2020
    All good - no bad experience.
  • 5.0
    June 18, 2020
    Dr. Ghatalia is very professional and explains everything in detail, she is also a very kind caring individual. It is always a pleasure to visit her at Fox Chase.
  • 5.0
    June 14, 2020
    She is the best!!!
  • 5.0
    May 25, 2020
    Great experience.
  • 5.0
    May 21, 2020
    Generally a very good experience
  • 5.0
    May 20, 2020
    I was very impressed that the first set of questions were COVID-19 related and then onto clinical trial questions.
  • 5.0
    May 19, 2020
    Very pleased with Dr. Pooja Ghatalia and staff.
  • 5.0
    April 28, 2020
    Dr. Ghatalia is very helpful, caring and saving my life.I am lucky she is my doctor and taking care of me.
  • 5.0
    April 24, 2020
    extremely pleased with Dr. Ghatalia as my oncologist health care provider. Trust her care decisions implicitly!
  • 5.0
    April 16, 2020
    Dr. Ghatalia is the finest doctor on the face of this earth. I feel the same for her nurse & staff.
  • 5.0
    February 26, 2020
    Everything was excellent.
  • 5.0
    February 04, 2020
    Our experience with Dr. Ghatalia has been nothing short of excellence. Such a caring and knowledgable doctor who provides guidance each step of the way. [...] Fox Chase is a First Class Act and we thank God we were guided to your care.
  • 5.0
    January 09, 2020
    Very good service and informative/very happy!
  • 4.0
    December 01, 2019
    Just started coming, so far is good.
  • 5.0
    November 26, 2019
    All staff is very friendly and seem genuinely compassionate, especially Dr. Ghatalia. This is a quality that is deeply appreciated.
  • 5.0
    November 24, 2019
    Excellent experience. Excellent.
  • 5.0
    October 30, 2019
    Made us feel comfortable.
  • 5.0
    October 30, 2019
    Excellent overall!

Connect with Fox Chase